LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Capricor Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCAPR
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CAPR COVERAGE

What’s moving Capricor Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

The story matters when it changes Capricor Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Rosen Law Firm Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Investors are testing whether Capricor Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Deadline Soon: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Deadline Soon: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Investors are testing whether Capricor Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Yahoo Finance

Capricor Therapeutics, Inc. (CAPR) Stock Price, News, Quote & History

Investors are testing whether Capricor Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application ...

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit

The story matters when it changes Capricor Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
CAPR INVESTORS: Kirby McInerney LLP Reminds Capricor Therapeutics, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm

CAPR INVESTORS: Kirby McInerney LLP Reminds Capricor Therapeutics, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm

The story matters when it changes Capricor Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CAPR filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-10 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-17 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-30 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-07-29 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-07-14 · Period 2026-07-09SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-10 · Period 2026-06-04SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-08-03SEC ↗
EARNINGS / QUARTERLY TRACKER

Capricor Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.